Krasner Alan Seth has filed 8 insider transactions across 1 company since May 2022.
Most recent transaction: a option exercise of 7000 shares of Crinetics Pharmaceuticals, Inc. ($CRNX) on October 17, 2023.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 17, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | M | Common Stock | 7000 | $12.01 | 50,210.0000 | 32,344,371,000 | 16.20% | 0.00% |
| Oct. 17, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | S | Common Stock | 7000 | $30.00 | 43,210.0000 | 32,344,371,000 | 13.94% | 0.00% |
| Oct. 17, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | M | Non-qualified stock option (Right to Buy) | 7000 | $0.00 | 153,473.0000 | 32,344,371,000 | 4.36% | 0.00% |
| March 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | F | Common Stock | 1687 | $17.12 | 42,301.0000 | 0 | 3.84% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | A | Common Stock | 19500 | $0.00 | 43,988.0000 | 0 | 79.63% | 0.00% |
| March 1, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | A | Common Stock (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2022 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | J | Common Stock | 1215 | $11.02 | 23,776.0000 | 0 | 5.39% | 0.00% |
| Nov. 20, 2022 | Crinetics Pharmaceuticals, Inc. | $CRNX | Krasner Alan Seth | Chief Medical Officer | J | Common Stock | 712 | $11.02 | 24,488.0000 | 0 | 2.99% | 0.00% |